Leptospira seropositivity as a risk factor for Mesoamerican Nephropathy

International Journal of Occupational and Environmental Health

Volumn 23, Issue 1, 2017, Pages 1-10

  Riefkohl, Alejandro ^a   Ramírez Rubio, Oriana ^a,b   Laws, Rebecca L ^a   McClean, Michael D ^a   Weiner, Daniel E ^c   Kaufman, James S ^d   Galloway, Renee L ^e   Shadomy, Sean V ^e   Guerra, Marta ^e   Amador, Juan José ^a   Sánchez, José Marcel ^a   López Pilarte, Damaris ^a   Parikh, Chirag R ^f,g   Leibler, Jessica H ^a   Brooks, Daniel R ^a  

^a BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g YALE UNIVERSITY   (United States)

Author keywords

Chronic kidney disease (CKD); Chronic kidney disease of nontraditional etiology (CKDnt); Ieptospirosis; Interleukin 18 (IL 18); Leptospira; Mesoamerican Nephropathy (MeN); N acetyl D glucosaminidase (NAG); Neutrophil gelatinase associated lipocalin (NGAL)

Indexed keywords

BACTERIUM ANTIBODY; BIOLOGICAL MARKER; CREATININE; INTERLEUKIN 18; LCN2 PROTEIN, HUMAN; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN;

ADULT; AGRICULTURAL WORKER; BLOOD; CHRONIC KIDNEY FAILURE; COMPLICATION; FEMALE; HUMAN; IMMUNOLOGY; LEPTOSPIRA; LEPTOSPIROSIS; MALE; MIDDLE AGED; NICARAGUA; PROSPECTIVE STUDY; SEROEPIDEMIOLOGY; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; ANTIBODIES, BACTERIAL; BIOMARKERS; CREATININE; FARMERS; FEMALE; HUMANS; INTERLEUKIN-18; LEPTOSPIRA; LEPTOSPIROSIS; LIPOCALIN-2; MALE; MIDDLE AGED; NICARAGUA; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 85013127968     PISSN: 10773525     EISSN: 20493967     Source Type: Journal    
DOI: 10.1080/10773525.2016.1275462     Document Type: Article

References (71)

1. Wesseling C, Crowe J, Hogstedt C, et al. Resolving the enigma of the Mesoamerican Nephropathy: a research workshop summary. Am J Kidney Dis. 2014;63(3):396–404.10.1053/j.ajkd.2013.08.014
2. Ordunez P, Saenz C, Martinez R, et al. The epidemic of chronic kidney disease in Central America. Lancet Global Health. 2014;2(8):e440–e441.10.1016/S2214-109X(14)70217-7
3. Orantes CM, Herrera R, Almaguer M, et al. Chronic kidney disease and associated risk factors in the Bajo Lempa region of El Salvador: Nefrolempa Study, 2009. MEDICC Rev. 2011;13(4):14–22.
4. Orantes CM, Herrera R, Almaguer M, et al. 2014. Epidemiology of chronic kidney disease in adults of salvadoran agricultural communities. MEDICC Rev. 2014;16(2): 23–30.
5. Weiner DE, McClean MD, Kaufman JS, et al. The Central American epidemic of CKD. Clin J Am Soc Nephrol. 2013;8(3):504–511.10.2215/CJN.05050512
6. Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican Nephropathy. Am J Kidney Dis. 2014;63(3):506–520.10.1053/j.ajkd.2013.10.062
7. Raines N, González M, Wyatt C, et al. Risk factors for reduced glomerular filtration rate in a Nicaraguan community affected by Mesoamerican Nephropathy. MEDICC Rev. 2014;16(2):16–22.
8. Ramirez-Rubio O, Brooks DR, Amador JJ, et al. Chronic kidney disease in Nicaragua: a qualitative analysis of semi-structured interviews with physicians and pharmacists. BMC Public Health. 2013;13:247.10.1186/1471-2458-13-350
9. Ramirez-Rubio O, McClean MD, Amador JJ, et al. An epidemic of chronic kidney disease in Central America: an overview. J Epidemiology Community Health. 2013;67(1):1–3.10.1136/jech-2012-201141
10. Wesseling C, Crowe J, Hogstedt C, et al. The epidemic of chronic kidney disease of unknown etiology in mesoamerica: a call for interdisciplinary research and action. Am J Public Health. 2013;103(11):1927–1930.10.2105/AJPH.2013.301594
11. O’Donnell JK, Tobey M, Weiner DE, et al. Prevalence of and risk factors for chronic kidney disease in rural Nicaragua. Nephrol Dial Transplant. 2011;26(9):2798–2805.10.1093/ndt/gfq385
12. Peraza S, Wesseling C, Aragon A, et al. Decreased kidney function among agricultural workers in El Salvador. Am J Kidney Dis. 2012;59(4):531–540.10.1053/j.ajkd.2011.11.039
13. Torres C, Aragón A, González M, et al. Decreased kidney function of unknown cause in Nicaragua: a community-based survey. Am J Kidney Dis. 2010;55:485–496.10.1053/j.ajkd.2009.12.012
14. Laws RL, Brooks DR, Amador JJ, et al. Changes in kidney function among Nicaraguan sugarcane workers. Int J Occup Environ Health. 2015;21(3):241–250. 10.1179/2049396714Y.0000000102. Epub 2015 Jan 28.
15. Wijkström J, Leiva R, Elinder CG, et al. Clinical and pathological characterization of Mesoamerican Nephropathy: a new kidney disease in Central America. Am J Kidney Dis. 2013;62(5):908–918.10.1053/j.ajkd.2013.05.019
16. Wesseling C, Crowe J, Hogstedt C, et al, editors. Mesoamerican Nephropathy: report from the first international research workshop on MeN. Heredia: SALTRA/IRET-UNA; 2013:81–85. [cited 2015 Nov] Available from: http://www.saltra.una.ac.cr/index.php/sst-vol-10.
17. Cuadra SN, Jakobsson K, Hogstedt C, et al Chronic kidney disease: assessment of current knowledge and feasibility for regional research collaboration in Central America. Work and Health Series, No. 2. Heredia: SALTRA, 20 IRET-UNA; 2006 [cited 2015 Nov]. Available from: http://www.saltra.una.ac.cr/index.php/sst-vol-2.
18. Pappas G, Papadimitriou P, Siozopoulou V, et al. The globalization of leptospirosis: worldwide incidence trends. Int J Infec Dis. 2008;12(4):351–357.10.1016/j.ijid.2007.09.011
19. World Health Organization. Leptospirosis Worldwide 1999. Weekly Epidemiological Record. 1999;74(29):237–244. [cited 2015 Nov] Available from: http://www.who.int/wer
20. Levett PN. Leptospirosis. Clin Microbiol Rev. 2001;14(2):296–326.10.1128/CMR.14.2.296-326.2001
21. Bharti AR, Nally JE, Ricaldi JN, et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis. 2003;3(12):757–771.10.1016/S1473-3099(03)00830-2
22. Haake DA, Dundoo M, Cader R, et al. Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis. 2002;34(9):e40–e43.10.1086/cid.2002.34.issue-9
23. Morgan J, Bornstein SL, Karpati AM, et al. Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis. 2002;34(12):1593–1599.10.1086/cid.2002.34.issue-12
24. Sejvar J, Bancroft E, Winthrop K, et al. Leptospirosis in “Eco-Challenge” Athletes, Malaysian Borneo, 2000. Emerg Infect Dis. 2003;9(6):702–707.10.3201/eid0906.020751
25. Waitkins SA. Leptospirosis as an occupational disease. Br J Ind Med. 1986;43(11):721–725.
26. Smythe L, Symonds M, Dohnt L, et al. Review of leptospirosis notifications in Queensland and Australia: January 1998–June 1999. Commun Dis Intell. 2000;24(6):153–157.
27. Bovet P, Yersin C, Merien F, et al. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol. 1999;28(3):583–590.10.1093/ije/28.3.583
28. Ashford DA, Kaiser RM, Spiegel RA, et al. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg. 2000;63(5–6):249–254.
29. Abdulkader RC, Silva MV. The kidney in leptospirosis. Pediatr Nephrol. 2008;23(12):2111–2120. 10.1007/s00467-008-0811-4. Epub 2008 Apr 30.
30. Katz AR, Ansdell VE, Effler PV, et al. Assessment of the clinical presentation and treatment of 353 cases of laboratory‐confirmed leptospirosis in Hawaii, 1974–1998. Clin Infect Dis. 2001;33(11):1834–1841.10.1086/cid.2001.33.issue-11
31. De Francesco Daher EF, Zanetta DMT, Abdulkader RC. Pattern of renal function recovery after leptospirosis acute renal failure. Nephron Clin Pract. 2004;98(1):c8–c12.10.1159/000079922
32. Coursin DB, Updike SJ, Maki DG. Massive rhabdomyolysis and multiple organ dysfunction syndrome caused by leptospirosis. Intensive Care Med. 2000;26(6):808–812.10.1007/s001340051252
33. Vinetz JM, Glass GE, Flexner CE, et al. Sporadic urban leptospirosis. Ann Intern Med. 1996;125(10):794–798.10.7326/0003-4819-125-10-199611150-00002
34. Heath JrCW, Alexander AD, Galton MM. Leptospirosis in the United States. Analysis of 483 cases in man, 1949–1961. N Engl J Med. 1965;273(17):857–864, 915–922.10.1056/NEJM196510142731606
35. O’Neil KM, Rickman LS, Lazarus AA. Pulmonary manifestations of leptospirosis. Rev Infect Dis. 1991;13(4):705–709.10.1093/clinids/13.4.705
36. Dupont H, Dupont-Perdrizet D, Perie JL, et al. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis. 1997;25(3):720–724.10.1086/cid.1997.25.issue-3
37. Marotto PC, Nascimento CM, Eluf-Neto J, et al. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis. 1999;29(6):1561–1563.10.1086/313501
38. Takafuji ET, Kirkpatrick JW, Miller RN, et al. An efficacy trial of doxycycline chemoprophylaxis against leptospirosis. N Engl J Med. 1984;310(8):497–500.10.1056/NEJM198402233100805
39. Yang CW, Wu MS, Pan MJ. Leptospirosis renal disease. Neprhol Dial Transplant. 2001;16(Suppl 5):73–77.10.1093/ndt/16.suppl_5.73
40. Covic A, Goldsmith DJA, Gusbeth-Tatomir P, et al. A retrospective 5-year study in Moldova of acute renal failure due to leptospirosis: 58 cases and a review of the literature. Nephrol Dial Transplant. 2003;18(6):1128–1134.10.1093/ndt/gfg095
41. Yang CW, Pan MJ, Wu MS, et al. Leptospirosis: an ignored cause of acute renal failure in Taiwan. Am J Kidney Dis. 1997;30(6):840–845.10.1016/S0272-6386(97)90091-3
42. Jayakumar M, Ram Prabahar MR, Fernando EM, et al. Epidemiologic trend changes in acute renal failure–a tertiary center experience from South India. Ren Fail. 2006;28(5):405–410.10.1080/08860220600689034
43. Visith S, Kearkiat P. Nephropathy in leptospirosis. J Postgrad Med. 2005;51(3):184–188.
44. Niwattayakul K, Homvijitkul J, Niwattayakul S, et al. Hypotension, renal failure, and pulmonary complications in leptospirosis. Ren Fail. 2002;24(3):297–305.10.1081/JDI-120005363
45. Daher EF, Zanetta DMT, Cavalcante MB, et al. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg. 1999;61(4):630–634.
46. Cengiz K, Şahan C, Sünbül M, et al. Acute renal failure in leptospirosis in the black-sea reagion in Turkey. Int Urol Nephrol. 2002;33(1):133–136.10.1023/A:1014494012062
47. Winearls CG, Chan L, Coghlan JD, et al. Acute renal failure due to leptospirosis: clinical features and outcome in six cases. Q J Med. 1984;53(212):487–495.
48. Herath NJ, Kularatne SA, Weerakoon KG, et al. Long term outcome of acute kidney injury due to leptospirosis? a longitudinal study in Sri Lanka. BMC Res Notes. 2014;7(1):398.10.1186/1756-0500-7-398
49. Coca SG, Yusuf B, Shlipak MG, et al. Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis. 2009;53(6):961–973.10.1053/j.ajkd.2008.11.034
50. Newsome BB, Warnock DG, McClellan WM, et al. Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction. Arch Int Med. 2008;168(6):609–616.10.1001/archinte.168.6.609
51. Yang HY, Hung CC, Liu SH, et al. Overlooked risk for chronic kidney disease after leptospiral infection: a population based survey and epidemiological cohort evidence. PloS Negl Trop Dis. 2015;9(10):e0004105. 10.1371/journal.pntd.0004105.
52. Laws RL, Brooks DR, Amador JJ, et al. Biomarkers of kidney injury among Nicaraguan sugarcane workers. Am J Kidney Dis. 2015;pii: S0272-6386(15)01157-9. 10.1053/j.ajkd.2015.08.022 [Epub ahead of print].
53. Lelu M, Muñoz-Zanzi C, Higgins B, et al. Seroepidemiology of leptospirosis in dogs from rural and slum communities of Los Rios Region, Chile. BMC Vet Res. 2015;11:31. 10.1186/s12917-015-0341-9.
54. Centers for Disease Control and Prevention (CDC) [Internet]. Leptospirosis (Leptospira interrogans) 2013 Case Definition. Page last updated: May 06, 2015. [cited 2015 Nov] Available from: http://wwwn.cdc.gov/nndss/conditions/leptospirosis/case-definition/2013/
55. Stoddard RA. Detection of pathogenic Leptospira spp. through real-time PCR (qPCR) targeting the LipL32 gene. Methods Mol Biol. 2013;943:257–266. 10.1007/978-1-60327-353-4_17.
56. Levey AS, Stevens LA, Schmid CH, et al. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604–612.10.7326/0003-4819-150-9-200905050-00006
57. Bolignano D, Lacquaniti A, Coppolino G, et al. Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin J Am Soc Nephrol. 2009;4(2):337–344.10.2215/CJN.03530708
58. Bonventre JV, Vaidya VS, Schmouder R, et al. Next-generation biomarkers for detecting kidney toxicity. Nat Biotechnol. 2010;28(5):436–440.10.1038/nbt0510-436
59. Charlton JR, Portilla D, Okusa MD. A basic science view of acute kidney injury biomarkers. Nephrol Dial Transplant. 2014;29(7):1301–1311.10.1093/ndt/gft510
60. Devarajan P. Neutrophil gelatinase‐associated lipocalin (NGAL): a new marker of kidney disease. Scand J Clin Lab Invest Suppl. 2008;68:89–94.10.1080/00365510802150158
61. Devarajan P. Biomarkers for the early detection of acute kidney injury. Curr Opin Pediatr. 2011;23(2):194–200.10.1097/MOP.0b013e328343f4dd
62. Liu Y, Guo W, Zhang J, et al. Urinary interleukin 18 for detection of acute kidney injury: a meta-analysis. Am J Kidney Dis. 2013;62(6):1058–1067.10.1053/j.ajkd.2013.05.014
63. Parikh CR, Abraham E, Ancukiewicz M, et al. Urine IL-18 Is an early diagnostic marker for acute kidney injury and predicts mortality in the intensive care unit. J Am Soc Nephrol. 2005;16(10):3046–3052.10.1681/ASN.2005030236
64. Smith ER, Lee D, Cai MM, et al. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD). Nephrol Dial Transplant. 2013;28(6):1569–1579.10.1093/ndt/gfs586
65. Vaidya VS, Ferguson MA, Bonventre JV. Biomarkers of acute kidney injury. Annu Rev Pharmacol Toxicol. 2008;48:463–493.10.1146/annurev.pharmtox.48.113006.094615
66. Obermüller N, Geiger H, Weipert C, et al. Current developments in early diagnosis of acute kidney injury. Int Urol and Nephrol. 2014;46(1):1–7.10.1007/s11255-013-0448-5
67. Bedford M, Farmer C, Levin A, et al. Acute kidney injury and CKD: chicken or egg? Am J Kidney Dis. 2012;59(4):485–491.10.1053/j.ajkd.2011.09.010
68. Venkatachalam MA, Griffin KA, Lan R, et al. Acute kidney injury: a springboard for progression in chronic kidney disease. Am J Physiol Renal Physiol. 2010;298(5):F1078–F1094.10.1152/ajprenal.00017.2010
69. Yang L, Humphreys BD, Bonventre JV. Pathophysiology of acute kidney injury to chronic kidney disease: maladaptive repair. Contrib Nephrol. 2011;174:149–155.10.1159/000329385
70. Levett PN. Usefulness of serologic analysis as a predictor of the infecting serovar in patients with severe leptospirosis. Clin Infect Dis. 2003;36(4):447–452.10.1086/cid.2003.36.issue-4
71. Ganoza CA, Matthias MA, Saito M, et al. Asymptomatic renal colonization of humans in the peruvian Amazon by leptospira. PLoS Negl Trop Dis. 2010;4(2):e612.10.1371/journal.pntd.0000612